UPDATE 1-Teva shares halted, market waits for $45 bln bid for Allergan

TEL AVIV, July 27 (Reuters) - The Tel Aviv Stock Exchange has suspended trading in Teva Pharmaceutical Industries as the market waits on a possible bid for Allergan Plc's generic drugs business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.